Have a personal or library account? Click to login
Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients Cover

Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients

Open Access
|Jan 2023

References

  1. 1Albanese A, Bhatia K, Bressman SB, et al., “Phenomenology and classification of dystonia: a consensus update.” Mov Disord. 2013; 28: 863873. DOI: 10.1002/mds.25475
  2. 2Singer C, Papapetropoulos S. “A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia.” Parkinsonism Relat Disord. 2006; 12: 115118. DOI: 10.1016/j.parkreldis.2005.07.007
  3. 3Balasubramaniam R, Rasmussen J, Carlson LW, Van Sickels JE, Okeson JP. “Oromandibular dystonia revisited: a review and a unique case.” J Oral Maxillofac Surg. 2008; 66: 379386. DOI: 10.1016/j.joms.2006.11.028
  4. 4Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. “A prevalence study of primary dystonia in eight European countries.” J Neurol. 2000; 247: 787792. DOI: 10.1007/s004150070094
  5. 5Merz RI, Deakin J, Hawthorne MR. “Oromandibular dystonia questionnaire (OMDQ-25): a valid and reliable instrument for measuring health-related quality of life.” Clin Otolaryngol. 2010; 35: 390396. DOI: 10.1111/j.1749-4486.2010.02194.x
  6. 6Slaim L, Cohen M, Klap P, et al., “Oromandibular dystonia: demographics and clinical data from 240 patients.” J Mov Disord. 2018; 11(2): 7881. DOI: 10.14802/jmd.17065
  7. 7Tan EK, Jankovic J. “Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.” Neurology. 1999; 53: 21022107. DOI: 10.1212/WNL.53.9.2102
  8. 8Scorr LM, Factor SA, Parra SP, et al., ̴Oromandibular Dystonia: A Clinical Examination of 2020 Cases.” Front Neurol. 2021; 12: 700714. DOI: 10.3389/fneur.2021.700714
  9. 9Yoshida K. “Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.” Toxins. 2019; 11(1): 51. DOI: 10.3390/toxins11010051
  10. 10Sinclair CF, Gurey LE, Blitzer A. “Oromandibular dystonia: long-term management with botulinum toxin.” Laryngoscope. 2013; 123: 30783083. DOI: 10.1002/lary.23265
  11. 11Bakke M, Larsen BM, Dalager T, Moller E. “Oromandibular dystonia–functional and clinical characteristics: a report on 21 cases.” Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 115: 2122. DOI: 10.1016/j.oooo.2012.04.023
  12. 12Papapetropoulos S, Singer CC. “Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations.” Head Face Med. 2006; 2: 47. DOI: 10.1186/1746-160X-2-47
DOI: https://doi.org/10.5334/tohm.730 | Journal eISSN: 2160-8288
Language: English
Submitted on: Oct 13, 2022
Accepted on: Jan 18, 2023
Published on: Jan 30, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Mehmet Balal, Meltem Demirkiran, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.